Clinical outcomes of endoscopic treatment in acute cholangitis: comparison between Tokyo guidelines 2018 and ASGE 2021
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S375-S376
DOI: 10.1055/s-0044-1783626 ↗Kurz gefasst
Leitlinie in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von M. De Ruvo und 7 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Aims
The optimal endoscopic approach during acute cholangitis (AC) remains controversial. There is currently no agreement on the timing of biliary drainage, nor on the endoscopic technique: Tokyo guidelines (TG18) recommend to perform only biliary drainage in several cases, because of the risk of bleeding after sphincterotomy (EST) in this setting; on the other hand ASGE guideline suggests to remove the cause of cholangitis (i.e. biliary stones) too in a single procedure (combined strategy), regardless of degree of severity. This study describes a case series of AC and compares findings with the reference guidelines.
Methods
We included patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) for AC in a single high volume center between december 2017 and december 2022. AC were stratified by severity according to TG18 criteria. Patients who had previously undergone EST were excluded.
Results
One hundred seventy-one patients with AC were included (n=83 male), 89.5% with a lithiasic etiology, 10.5% with malignancy. Forty-five of them (26%) presented mild AC, 90 (53%) moderate AC and 36 (21%) severe AC, with a mortality rate of 0%, 1.2% and 19.4% respectively. Ninety-three patients (54.5%) underwent ERCP within 72 hours of diagnosis. Stratifying patients by cholangitis severity, there was no association between 30-day mortality and the timing of ERCP (within 24 hours, between 24 and 48 hours, between 48 and 72 hours after diagnosis or later), even in severe AC. Since EST was performed in most patients (94%), bleeding occurred only after EST and in 39 of them (24%). Patients with concomitant cholecystitis (n=33) or other infections (n=16) had a higher bleeding rate (39% and 62.5% respectively) compared to those without any other infections (20%) (p
Zitieren
APA
Ruvo, M. D., Grillo, S., Vicentini, M., Mirante, V. G., Cecinato, P., Bassi, F., Savarino, E., & Sassatelli, R. (2024). Clinical outcomes of endoscopic treatment in acute cholangitis: comparison between Tokyo guidelines 2018 and ASGE 2021. Endoscopy, 56(S 02 S 02), S375-S376. https://doi.org/10.1055/s-0044-1783626
Vancouver
Ruvo MD, Grillo S, Vicentini M, Mirante VG, Cecinato P, Bassi F, et al. Clinical outcomes of endoscopic treatment in acute cholangitis: comparison between Tokyo guidelines 2018 and ASGE 2021. Endoscopy. 2024;56(S 02 S 02):S375-S376. doi:10.1055/s-0044-1783626
BibTeX
@article{Ruvo2024,
author = {Ruvo, M. De and Grillo, S. and Vicentini, M. and Mirante, V. G. and Cecinato, P. and Bassi, F. and Savarino, E. and Sassatelli, R.},
title = {Clinical outcomes of endoscopic treatment in acute cholangitis: comparison between Tokyo guidelines 2018 and ASGE 2021},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S375--S376},
doi = {10.1055/s-0044-1783626}
}
EUVIMED